Tumores neuroendócrinos de colon y recto

Referencias

1. Regula J, Rupinsky M, Kraszewska E, Polkowsky M, Pachlewsky J, Orlowska J, Butruk E. Colonoscopy in colorectal-cancer scree­ning for detection of advanced neoplasia. N Engl J Med 2006; 355: 1863-1872.
2. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 car­cinoid tumors. Cancer 2003; 97: 934-959.
3. Caplin M, Sundin A, Nillson O, Baum R, Klose K, Kelestimur F, Plôckinger U, Papotti M, Salazar R, Pascher A and all other Barcelona Consensus Conferences Participants. ENETs Consen­sus Guidelines for the Managements of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms. Neuroendocrinology 2012; 95: 88-97.
4. Modlin IM, Latich I, Kidd M, Zikusoka, MN, Shapiro MD. Cu­rrent status of gastrointestinal carcinoids. Gastroenterology 2005; 128: 1717-1751.
5. Tichansky DS, Cagir B, Borrazzo E. Risk of second cancer in pa­tients with colorectal carcinoids. Dis Colon Rectum 2002; 45: 91-97.
6. Caplin M, Sundin A, Nillson O, Baum RP, Klose KJ, Kelestimur F, Plöckinger U, Papotti M, Salazar R, Pascher A. Barcelona Consen­sus Conference participants. ENETS Consensus Guidelines for the management with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms. Neuroendocrinology 2012; 95: 88-97.
7. Starzynska T, Deptala A, Królicki L, Kunikowska J, Londzin- Olesik M, Nasierowska-Guttmejer A, Ruchala M, Strzelczyk J, Szawlowski A. Consensus Conference, Polish Network of Neu­roendocrine Tumors. Colorectal neuroendocrine neoplasms-ma­nagement guidelines. Endokrynol Pol 2013; 64: 494-504.
8. Ramage JK, De Herder WW, Delle Fave G, Ferolla P, Ferone D, Ito T, Ruszniewski P, Sundin A, Weber W, Zheng-Pei Z, Taal B, PascherA. Vienna Consensus Conference participants. ENETS Consensus Guidelines update for colorectal neuroendocrine neo­plasms. Neuroendocrinology 2016; 103: 139-143.
9. Ramage J, Ahmed A, Ardill J, Bax N, Breen DJ, Caplin ME, Da­var J, Lewington V, Grossman AB. Guidelines for the manage­ment of gastroenteropancreatic neuroendocrine (including carci­noid) tumours (NETs). Gut 2012; 61: 6e32.
10. La Rosa S, InzaniF, Vanoli A, Klersy C, Dainese L, Rindi G. His­tologic characterization and improved prognostic evaluation of 209 gastric-neuroendocrine neoplasms. Hum Pathol 2011; 42: 1373-1384.
11. Bogacka B, Marlicz W, Bialek A. Trends in colorectal neuroendo­crine tumors: A 10 years review. Gut 2009; 58: A296.
12. Korse CM, Taal BG, Van Velthuysen ML, Visser O. Incidence and survival of neuroendocrine tumors in the Netherlands according to histological grade: Experience of two decades of cancer registry. Eur J Cancer 2013; 49: 1975-1983.
13. Shia J, Tang LH, Weiser MR, Brenner B, Adsay NV, Stelow EB, Saltz LB, Qin J, Landmann R, Leonard GD. Is non-small cell type high-grade neuroendocrine carcinoma of the tubular gastrointes­tinal tract a distinct disease entity? Am J Surg Pathol 2008; 32: 719-731.
14. Sorbye H, Strosberg J, Baudin E, Klimstra DS, Yao JC. Gastroen­teropancreatic high-grade neuroendocrine carcinoma. Cancer 2014; 120: 2814-2823.
15. La Rosa S, Klersy C, Uccella S, Dainese L, Albarello, L., Sonzogni, A., Doglioni, C.,Capella C., Solcia E.: Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. Pathol 2009; 40: 30-40.
16. La Rosa S, Marando A, Sessa F.: Mixed adenoneuroendocrine carcinomas (MANECs) of the gastrointestinal tract: An update. Cancer 2012; 4: 11-30.
17. Liu TC, Hamilton N, Hawkins W, Gao F, Cao D. Comparison of WHO classifications (2004, 2010), the Hochwald grading sys­tem, and AJCC and ENETS staging systems in predicting prog­nosis in locoregional well-differentiated pancreatic neuroendocri­ne tumors. Am J Surg Pathol 2013; 37, 853-859.
18. Elder DE, Massi D, Scolyer RA, Willemze R. The WHO classi­fication of tumors of digestive system. IARC: 2017. 4th Edition, Volume 11.
19. ENETS Consensus Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumors. Neuroendocrinology 2009; 90: 159-233.
20. Shim KN, Yang SK, Myung SJ, Chang HS, Jung SA, Choe JW, Lee YJ, Byeon JS, Lee JH, Jung HY. Atypical endoscopic features of rectal car¬cinoids. Endoscopy 2004; 36: 313-316.
21. Fang C, Wang F, Zhang W, Feng Y, Sun J, Zeng Y, Chen Y, Chen M, Zhou Z, Chen J. Clinipathologic characteristics and prognosis of the gastro-entero-pancreatic neuroendocrine neoplasms: a mul­ticenter study in South China. Chin J Cancer 2017; 36.
22. Konishi T, Watanabe T, Kishimoto J, Kotake K, Muto T, Nagawa H. Prognosis and risk factors of metastasis in colorectal carcinoids: re­sults of a nationwide registry over 15 years. Gut 2007; 56: 863-868.
23. Fahy BN, Tang LH, Klimstra D, Wong WD, Guillem JG, Paty PB, Temple LK, Shia J, Weiser MR: Carcinoid of the rectum risk stratification (CaRRs): astrategy for preoperative outcome as­sessment. Ann Surg Oncol 2007; 14:1735-1743.
24. Finnerty BM, Gray KD, Fahey T III: Epigenetics of gastroentero­pancreatic neuroendocrine tumors. World J Gastrointest Oncolo­gy 2017; 9: 341-351.
25. Shen C, Yin Y, Chen H, Tang S, Yin X, Zhou Z, Zhang B, Chen Z. Neuroendocrine tumors or colon and rectum: validation of clinical and prognostic values of the World Health Organization 2010 grading classifications and European Neuroendocrine Tu­mor